Radiopharmaceuticals are those radioisotopes that are primarily used for diagnosis and therapeutic purposes. Radioisotopes can be used for diagnosis and treatment of various chronic diseases. Radioisotopes play a very crucial part in the medical diagnostic procedures. In combination with imaging devices which record the gamma rays emitted from inside, healthcare professionals can study the dynamic processes taking place in various parts of the body. The Americas dominate the global Radiopharmaceuticals market owing to the presence of huge patient population suffering from various chronic diseases like cancer, coronary disorders, stroke among others, changing lifestyle and increasing research & development for effective and therapies with no side effects. In 2018, the global Radio Pharmaceutical market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Radio Pharmaceutical status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Radio Pharmaceutical development in United States, Europe and China. The key players covered in this study Jubilant Life Sciences Ltd. Siemens AG Sun Pharmaceutical Industries Ltd. Bayer AG Cardinal Health Inc. Medtronic General Electric Company (GE Healthcare) Lantheus Medical Imaging, Inc. Advanced Accelerator Applications S.A. Mallinckrodt Pharmaceuticals Nordion, Inc. Canadian Nuclear Laboratories (CNL) Bracco Diagnostic Inc. IBA Dosimetry GmbH Avid Radiopharmaceuticals Market segment by Type, the product can be split into Myocardial Perfusion Scan Lung Scan Others Market segment by Application, split into Oncology Cardiology Others Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Radio Pharmaceutical status, future forecast, growth opportunity, key market and key players. To present the Radio Pharmaceutical development in United States, Europe and China. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by product type, market and key regions. In this study, the years considered to estimate the market size of Radio Pharmaceutical are as follows: History Year: 2014-2018 Base Year: 2018 Estimated Year: 2019 Forecast Year 2019 to 2025 For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Radio Pharmaceutical Market Size Growth Rate by Type (2014-2025) 1.4.2 Myocardial Perfusion Scan 1.4.3 Lung Scan 1.4.4 Others 1.5 Market by Application 1.5.1 Global Radio Pharmaceutical Mark
